FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

CHOLAFIN Consensus Forecast

No. of reports in last year
6
No. of analysts
5
Average Consensus Forecast
530.17
Consensus Potential
2.25%

CHOLAFIN Price Target Potential

BrokerageTargetPotential
HDFC Securities61320.53%
Prabhudas Lilladher61921.30%
Motilal Oswal64023.88%
Axis Direct5053.53%
Nirmal Bang4941.39%

CHOLAFIN Targets in FrontPage Forums

9 Users have submitted 10 trade ideas of Rs. 765,839.06 for CHOLAFIN
70% Bullish
30% Bearish
See buy or sell ideas on FrontPage Forums >>

CHOLAFIN Ratings

Long term CHOLAFIN rating by FrontPage users
5/5 (5 Ratings)

6 CHOLAFIN share price target reports by brokerages below. See what is analyst's view on CHOLAFIN share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
  1. Home
  2. CHOLAFIN Forum
  3. CHOLAFIN Price Target

CHOLAFIN Share Price Target

CHOLAFIN Share Price Target - Broker Reports - 2021

11-May-21
Price @ Call: 550.55
Target: 613
BUY
10-May-21
Price @ Call: 553.9
Target: 619
BUY
19-Mar-21
Price @ Call: 552.7
Target: 640
BUY
2-Feb-21
Price @ Call: 460.45
Target: 505
BUY
1-Feb-21
Price @ Call: 429.96
Target: 494
BUY

CHOLAFIN Share Price Target - Broker Reports - 2020

30-Oct-20
Price @ Call: 269.47
Target: 310
BUY
4-Jun-20
Price @ Call: 146.8
Target: 179
ACCUMULATE
CIFC Q4FY20 earnings disappointed on several counts: (a)76% customers falling under morat, similar percentage expected in round 2; (b)Rs2.5bn additional provisions over & above Rs2.8bn contingency provisions in anticipation of increased LGDs for stage 3 assets (current Stage 3 at 3.8%) (c)steep 24%QoQ decline in disbursements led by 21%QoQ vehicle finance (VF) and 35%QoQ home equity (HE) decline. While liquidity sufficiency (Rs65bn cash on BS, Rs100bn sanctioned pipe-line) is expected to maintain ALM positioning over morat period, our apprehensions emerge from elongated asset quality downcycle led by meaningful morat quantum (~Rs450bn) spread across 6 months and bleak outlook on transport activity uptick post complete lockdown lift. Against this backdrop, we build weak growth cycle (4-12%), NIM compression (5-6%) and NPA jump (4-5%) over FY21-22E. To that effect our EPS estimates stand down by 60% for FY21 & 6% for FY22. While FY21 return profile takes a beating (RoE:4%/RoA:~1%), CIFC’s continued focus on right product positioning and conservative strategy place the Co. on revival mode. Resultantly, FY22 RoE/RoA bounce back to 16%/2% levels respectively. While unique pandemic challenges are calling for weakness in structural growth levers, we downgrade the stock to ACCUMULATE (earlier BUY). We assign a target multiple of 1.8x PBV FY22E arriving at a price target of Rs189 (earlier Rs229).
... Read more
26-Feb-20
Price @ Call: 318.45
Target: 390
BUY
There are two aspects of CIFC’s vehicle finance business that stand out compared to most peers: (i) it is well diversified across product segments and (ii) there is no state-level concentration – the largest state accounts for only 11% of total portfolio. While CIFC has managed to deliver 20%+ disbursement and AUM growth in the past, we expect it to slow down to ~15% over the medium term. There could also be ~30bp rise in credit costs unless the macro environment improves. While our estimates on growth and profitability remain largely unchanged, we incorporate the impact of the recent INR9b QIP in our numbers. This results in a 3% increase in our EPS estimate for FY21. Maintain Buy with a target price of INR390 (2.7x FY22E BVPS).
... Read more
10-Feb-20
Price @ Call: 335.08
Target: 441
BUY
Cholamandalam Investment and Finance Company Ltd (CIFC) is a well diversified play in secured asset segments such as vehicle finance and home equity (loan again property). Diversification across segments/geographies and better access to funds (via parentage and strong credit practices) is enabling CIFC to withstand sectoral headwinds.
CIFC has sustained ROAA/ ROAE at 1.9-2.3%/17-22% since FY13. Given its strong market positioning across credit/liquidity cycles led by strategic diversification, robust underwriting and healthy liquidity line-up, we are positive on the stock.
We initiate with a “BUY” and arrive at a target price of Rs 411 (3.2x FY22 ABV & 2.5x Post QIP).
... Read more
24-Jan-20
Price @ Call: 324.1
Target: 353
BUY
Despite robust business traction, Stage 3 assets deteriorated slightly from 3.18% in Q2FY20 to 3.3% in Q3FY20 (but down 20bps YoY). Inspite of modest deterioration, provisions spiked 42-43% YoY/QoQ. While increased provisioning led to PAT miss [PLe of Rs4.01bn], prudency in uncertain times is comforting. Moreover, caution on disbursements (-2.2% YoY) should arrest any incremental delinquencies in new portfolio. Yet we adequately incorporate conservatism in the form of credit costs at 0.9-1.0%, GNPA at 2.75% and NIMs at 6%, expecting stable return profile - RoAs 2.2%/RoE:19.6% over FY21-22E. CIFC’s strong market positioning across credit/liquidity cycles led by strategic diversification, robust underwriting and healthy liquidity line-up prompt us to reiterate BUY. At Sep-21 PABV, we value CIFC at 3.2x arriving at TP of Rs353.
... Read more

CHOLAFIN Share Price Target - Broker Reports - 2019

13-Nov-19
Price @ Call: 298.71
Target: 350
BUY
CIFC has a diversified portfolio, both in terms of geography and product. It is also expanding into new segments like home loans and MSME financing. Over the near term, we expect a meaningful slowdown in AUM growth and look to closely monitor asset quality. Thus, we cut our FY20/FY21 EPS estimates by 4% to factor in the lower growth. Buy with TP of INR350 (2.8x Sep’21 BVPS).
... Read more
6-Nov-19
Price @ Call: 301.53
Target: 354
BUY
The market headwinds and the conservative approach made its presence felt in decelerating fresh disbursements during Q2FY20 for CIFC. While the same de-grew 14% QoQ, focus on right product mix enabling market share gains in key higher yielding products, HE buoyancy at pre-demo levels and early default indicators enabled CIFC clock healthy AUMs at Rs592bn (PLe: Rs586bn) growing 24%YoY/3%QoQ. Opex remained elevated as Co. stepped- up collection efforts and increased manpower (in select businesses where there’s scope to catch up market share) rightly compensated by stable core (NII healthy 25%YoY/8% QOQ, operating profit up 17%YoY/4%QoQ) and controlled credit costs (0.7% on Stage 3 ECL). While business seasonality saw moderate deterioration in asset quality and funding, H2FY20 should witness trend reversals. We adequately incorporate conservatism in the form of credit costs at 0.9-1.0%, GNPA at 2.75%, AUM 17% growth and NIMs at 6%, expecting stable return profile - RoAs 2.2%/RoE:19% over FY21-22E. CIFC’s strong market positioning across credit/liquidity cycles led by strategic diversification, robust underwriting and healthy liquidity line-up prompt us to reiterate BUY. At Sep-21 PABV, we value CIFC at 3.1x arriving at TP of Rs354.
... Read more
31-Jul-19
Price @ Call: 250.78
Target: 372
BUY
Yet again, CIFC outperformed across operational parameters, amidst an increasingly tough economic environment. Maintain BUY with a TP of Rs 372 (3.5x Jun- 21E ABV).Growing polarization in the NBFC space (stemming from better parentage and access to funds) has enabled CIFC to sustainably outperform peers across operating metrics. Diversification across products and geographies along with superior underwriting practices and focus on collections pave the way for sustained outperformance. However, with deteriorating macros, asset quality (across asset financiers) will be watched.
... Read more
1-Aug-19
Price @ Call: 263.29
Target: 315
BUY
We are lowering our EPS estimates for FY20/FY21 by 6%/9%, as we cut volumes/margins for both businesses. The stock trades at ~22.3x/19x FY20E/FY21E consol. EPS. We have lowered P/E multiple for RE from 22.5x to 20x to factor in the step-down in its growth trajectory.Maintain Buy.
... Read more
31-Jul-19
Price @ Call: 241.8
Target: 322
BUY
While business seasonality saw tad slip-ups and increased BS liquidity and funding costs pressures dented NIMs, H2FY20 should witness yield and asset quality improvement. Despite factoring adequate conservatism in the form of credit costs at 0.9-1.0%, GNPA at 2.75%, AUM 17% growth and NIMs at 6%, we expect RoAs at 2.3% over FY20-21E. We reiterate BUY, reckon CIFC stands better placed to sail across credit/liquidity cycles led by strategic diversification across products and geographies. At Sep-21 PABV, we value the company at 3.1x arriving at TP of Rs322.
... Read more
2-May-19
Price @ Call: 268.51
Target: 62
ACCUMULATE
We expect Exide to benefit from: 1) an expected improvement in the replacement demand, given healthy primary sales in the past three years, 2) a market share gain from unorganized players, after GST implementation, 3) an uptick in the nascent e-rickshaws /solar battery segments, 4) the initiative to strengthen distribution network through the introduction of the sub-distributor model, and 5) the decline in lead prices (15% YoY), which will improve margin. We expect a 21% EPS CAGR over FY19-21E led by 13% revenue growth (driven by replacement demand) and 70bps margin expansion (due to weak lead prices and measures to cut costs). We recommend a Buy, with SOTP-based TP of ` 277 (20x FY21E EPS + 2x Inv (Rs 37) for the insurance).
... Read more
1-May-19
Price @ Call: 279.34
Target: 66.6
BUY
The high growth exhibited in Q4 might not repeat ahead; we build in adequate conservatism into our 3-year estimates. Said that, CIFC has sufficient levers in place to stack up overall RoAs to 2.3-2.4% over FY20-21E largely led by lower credit costs trends (0.9%-1.0%) and steady 17-18% AUM traction that should cushion NIMs (6% NIMs on AUMs) over FY20-21E. We reiterate BUY, reckon CIFC as one of the better placed auto financiers sailing successfully across credit and liquidity cycles with clear execution skills, prudent Management cognizant of portfolio quality and strategic product placement aiding growth and margins. At Sep-21 PABV, we value the company at 3.2x arriving at TP of Rs 1,665 (unchanged).
... Read more
30-Mar-19
Price @ Call: 291.24
Target: 67.24
BUY
The mgt expects growth to be driven by mkt share gains in the higher yielding used CV and 2-W segments. Margins would not be impacted as yields rise (increase in the share of higher-yielding assets, re-pricing of HE loans) in line with CoF. Asset quality improvement can be expected in both the VF (despite being one of the best) and HE segments as SARFAESI recoveries gather pace. The mgt thus targets pre-tax RoAAs of ~3.6-4%. Maintain BUY with a TP of Rs 1681 (3.25x FY21E ABV of Rs 517).
... Read more
4-Feb-19
Price @ Call: 244.77
Target: 54.4
ACCUMULATE
2-Feb-19
Price @ Call: 244.74
Target: 64.44
BUY
1-Feb-19
Price @ Call: 244.74
Target: 61
BUY
1-Feb-19
Price @ Call: 234
Target: 62.48
BUY
16-Jan-19
Price @ Call: 239.92
Target: 64.64
BUY
17-Jan-19
Price @ Call: 237
Target: 61
BUY

CHOLAFIN Share Price Target - Broker Reports - 2018

19-Nov-18
Price @ Call: 248.34
Target: 56.12
BUY
31-Oct-18
Price @ Call: 251.16
Target: 62.12
BUY
31-Oct-18
Price @ Call: 251.16
Target: 62.44
BUY
10-Sep-18
Price @ Call: 57.72
Target: 72.64
BUY
29-Aug-18
Price @ Call: 290.23
Target: 75.24
BUY
24-Aug-18
Price @ Call: 292.86
Target: 46
SELL
30-Jul-18
Price @ Call: 288.86
Target: 70.56
BUY
30-Jul-18
Price @ Call: 292.69
Target: 77.64
BUY
28-Jul-18
Price @ Call: 300.26
Target: 68
BUY
15-Jun-18
Price @ Call: 322.63
Target: 77.68
BUY
24-Apr-18
Price @ Call: 335.09
Target: 70.68
BUY
25-Apr-18
Price @ Call: 329.92
Target: 77.2
BUY
23-Feb-18
Price @ Call: 1375.25
Target: 1550
BUY
31-Jan-18
Price @ Call: 1284.25
Target: 1520
BUY

CHOLAFIN Share Price Target - Broker Reports - 2017

19-Dec-17
Price @ Call: 1274
Target: 1470
BUY
8-Nov-17
Price @ Call: 1263
Target: 1400
BUY
2-Aug-17
Price @ Call: 1179
Target: 1370
BUY
5-Jul-17
Price @ Call: 1112.85
Target: 1350
HOLD
27-Jun-17
Price @ Call: 1077.8
Target: 1296
BUY
24-Mar-17
Price @ Call: 972
Target: 1075
BUY
27-Jan-17
Price @ Call: 1045
Target: 1320
BUY
2-Feb-17
Price @ Call: 1046
Target: 1075
HOLD
27-Jan-17
Price @ Call: 1040
Target: 1350
BUY
30-Jan-17
Price @ Call: 1048
Target: 1335
BUY
19-Jan-17
Price @ Call: 1000
Target: 1230
BUY

CHOLAFIN Share Price Target - Broker Reports - 2016

17-Nov-16
Price @ Call: 999
Target: 1162
BUY
3-Nov-16
Price @ Call: 1140
Target: 1335
BUY
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 2,00,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • CHOLAFIN Share Price Target Today- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3508.17
    Upside Target 2499.58
    Upside Target 1487.67
    Pivot479.08
    Downside Target 1467.17
    Downside Target 2458.58
    Downside Target 3446.67
  • CHOLAFIN Share Price Target weekly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3533.35
    Upside Target 2519.55
    Upside Target 1497.65
    Pivot483.85
    Downside Target 1461.95
    Downside Target 2448.15
    Downside Target 3426.25
  • CHOLAFIN Share Price Target monthly- Technical Pivot Points (Classic)

    keyboard_arrow_down
    Upside Target 3634.48
    Upside Target 2609.62
    Upside Target 1561.43
    Pivot536.57
    Downside Target 1488.38
    Downside Target 2463.52
    Downside Target 3415.33
  • CHOLAFIN Share Price Target today- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3499.58
    Upside Target 2491.75
    Upside Target 1486.91
    Pivot479.08
    Downside Target 1471.25
    Downside Target 2466.41
    Downside Target 3458.58
  • CHOLAFIN Share Price Target weekly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3519.55
    Upside Target 2505.91
    Upside Target 1497.49
    Pivot483.85
    Downside Target 1470.21
    Downside Target 2461.79
    Downside Target 3448.15
  • CHOLAFIN Share Price Target monthly- Technical Pivot Points (Fibonacci)

    keyboard_arrow_down
    Upside Target 3609.62
    Upside Target 2581.71
    Upside Target 1564.47
    Pivot536.57
    Downside Target 1508.66
    Downside Target 2491.42
    Downside Target 3463.52
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.
PrivacyTerms
FrontPage © 2020